Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2)
2012-004108-37Phase 3Completed
- Sponsor
- University of Nottingham
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Primary Intracerebral Hemorrhage (ICH) and intracerebral hemorrhage (ICH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Death or dependency after primary intracerebral haemorrhage. Started Sep 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Primary Intracerebral Hemorrhage (ICH)intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2012-004108-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004108-37.